Malaria Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00007610
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Malaria Diagnostics Market Scope, Growth, Size and Share by 2030

Buy Now

Malaria Diagnostics Market Report Malaria Diagnostics Market Size and Share Malaria Diagnostics Market Scope and Analysis

Malaria Diagnostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 782.57 Million
Market Size by 2030 US$ 1,200.24 Million
Global CAGR (2022 - 2030) 5.5%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Technology
  • Microscopy
  • Rapid Diagnostic Tests
  • Molecular Diagnostic Tests
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Access Bio Inc
  • Abbott Laboratories
  • Premier Medical Corporation Pvt Ltd
  • Sysmex Partec GmbH
  • bioM rieux
  • Beckman Coulter Inc
  • Siemens Healthineers
  • Leica Microsystems GmbH
  • Nikon Corporation

    • Industry Developments and Future Opportunities: 

    Various strategic developments by leading players operating in the malaria diagnostics market are listed below:

    • In February 2022, the Kenya Medical Research Institute (KEMRI) launched Plasmochek for Malaria testing. Plasmochek is designed to detect plasmodium, a parasite responsible for causing malaria. The kit utilizes antibodies specific to Plasmodium falciparum histidine-rich protein II and Plasmodium lactate dehydrogenase to detect malaria infections.
    • In Dec 2019, Access Bio and Global Good (a collaboration partner of the former) developed a new ultra-sensitive rapid diagnostic test (uRDT) that is five times more sensitive in identifying histidine-rich protein 2 (HRP2) antigens than currently available uRDTs. Additionally, a variety of tools have been created to improve malaria diagnosis.

    Competitive Landscape and Key Companies:

    Access Bio., Inc.; Abbott Laboratories; Premier Medical Corporation Pvt. Ltd.; Sysmex Partec GmbH; bioMerieux; Beckman Coulter Inc.; Siemens Healthineers; Leica Microsystems GmbH; Nikon Corporation; Olympus Corporation; and Bio-Rad Laboratories Inc. are the prominent companies in the malaria diagnostics market. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide.